Search for Current Clinical Trials

Study Name Description Trial Category Trial SubCategory
A DUE Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) Heart & Vascular Pulmonary Hypertension
A011502 A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial Cancer Breast
A021502 Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair Cancer Gastrointestinal
A021703 Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS) Cancer Gastrointestinal
A031501 Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation Cancer Bladder/Urothelial
A031803 Phase II Trial of Intravesical Gemcitabine and MK-3475 (pembrolizumab) in the Treatment of Patients with BCG-Unresponseve Non-Muscle Invasive Bladder Cancer Cancer Bladder
A041702 Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (= 70 Years of Age) Cancer Hematology
A061202 A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib VS. Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Relapsing on Lenalidomide as Part of First Line Therapy Cancer Multiple Myeloma
A081105 Randomized, Double-blind, Placebo COntrolled Study of erlotinib or placebo in Patients with Completely Resected Epidermal Growth factor Receptor (EGFR) mutant Non-Small Cell Lung Cancer (NSCLC) Cancer Lung
A171601 A Phase II Trial Assessing the Tolerability of Palbociclib in Combination with Letrozole or Fulvestrant in Patients Aged 70 and Older with Estrogen Receptor-positive, HER2-negative Cancer Breast - Metastatic
AALL08B1 Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) Childhood Cancers Leukemia
AALL0932 Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) Childhood Cancers Leukemia
AALL1231 A Phase lll Randomized Trial Investigating Bortezomib (NSC#681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy) Childhood Cancers Leukemia
AALL1521 A Phase 2 study of the JAK1/JAK2 Inhibitor Ruxolitinib with Chemotherapy in Children with De Novo High-Risk CRLF2 Rearranged and/ or JAK Pathway-Mutant Acute Lymphoblastic Leukemia Childhood Cancers Leukemia
Acoustic Diagnosis of Gastroesophageal Reflux Disease Baby/Child Reflux Disease
AIM Power The goal of this real-world, multi-center, randomized, outpatient study is to assess the effectiveness of the Biofourmis cloud based BiovitalsHFTM Clinical Decision Support Platform to recommend optimal titration of Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) subjects. Heart & Vascular Heart Failure
ANBL1232 Utilizing Response-and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High Risk Neuroblastoma Childhood Cancers Blastoma
Ant 004 This is a study of a new anticoagulant vs. placebo in Afib. Heart & Vascular Atrial Fibrillation
ANT-004 / Azalea Heart & Vascular Atrial Fibrillation
APEC14B1 EveryChild A Registry, Eligibility Screening, Biology and Outcome Study Childhood Cancers Registry
Artesia Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation Heart & Vascular Atrial Fibrillation
Champion AF The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation. Heart & Vascular Atrial Fibrillation
COG-AALL05B1 Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens Childhood Cancers Leukemia
COG-AALL1331 Risk Stratified Randomized Phase lll Testing of blinatumomab (IND#117467, NCS#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) Childhood Cancers Leukemia
COG-ACNS0332 Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other than Average Risk Medulloblastoma/PNET Patients Childhood Cancers Blastoma
COG-ACNS0831 Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years Childhood Cancers Glioma
COG-AEWS07B1 A Children's Oncology Group Protocol for Collecting and Banking Ewing Sarcoma Specimens Childhood Cancers Sarcoma
COG-AHEP0731 Treatment of Children with All Stages of Hepatoblastoma Childhood Cancers Blastoma
COG-AHOD1331 A randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND # 117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents Childhood Cancers Lymphoma
COG-ANBL00B1 Neuroblastoma Biology Studies Childhood Cancers Blastoma